PNC Financial Services Group
DYN icon

PNC Financial Services Group’s Dyne Therapeutics DYN Stock Holding History

PNC Financial Services Group’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.6K Buy
1,280
+743
+138% +$17.1K ﹤0.01% 3834
2026
Q2 		$11.9K Sell
537
-384
-42% -$7.14K ﹤0.01% 4013
2026
Q1 		$16.7K Buy
921
+503
+120% +$8.67K ﹤0.01% 3767
2025
Q4 		$8.18K Sell
418
-42
-9% -$795 ﹤0.01% 4041
2025
Q3 		$5.82K Buy
460
+250
+119% +$2.85K ﹤0.01% 4143
2025
Q2 		$2K Buy
210
+185
+740% +$2.04K ﹤0.01% 4409
2025
Q1 		$262 Buy
25
+4
+19% +$57 ﹤0.01% 4743
2024
Q4 		$495 Sell
21
-119
-85% -$3.52K ﹤0.01% 4532
2024
Q3 		$5.03K Buy
140
+111
+383% +$4.42K ﹤0.01% 4036
2024
Q2 		$1.02K Buy
29
+19
+190% +$552 ﹤0.01% 4418
2024
Q1 		$284 Buy
+10
New +$226 ﹤0.01% 4565

Other funds holding DYN

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

PNC Financial Services Group's DYN Position: Q3 2026 in Review

PNC Financial Services Group increased its Dyne Therapeutics (DYN) stake by 138% in Q3 2026, buying an estimated $17.1K and bringing the position to 1,280 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3834.

PNC Financial Services Group first reported a position in DYN in Q1 2024 and has held it in 11 quarters since. 179 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • PNC Financial Services Group held 1,280 shares of Dyne Therapeutics worth $20.6K as of Q3 2026.
  • PNC Financial Services Group bought 743 Dyne Therapeutics shares in Q3 2026, an estimated $17.1K.
  • Dyne Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3834 holding.
  • PNC Financial Services Group first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 11 quarters since.
  • 179 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.